The experience with molar sodium lactate has been extended to include 101 patients. Certain indications and relative contraindications to its use have crystallized. Administration of this agent is shown to be a physiologic and effective method for treating patients with severe hyperpotassemia, multiple Stokes-Adams, attacks, and cardiac arrest, particularly that occurring in the operating room complicating cardiac surgery. For many patients in these categories, sodium lactate was life saving even though it was generally given after other more commonly used drugs and methods of therapy had proved ineffective in restoring cardiac rhythm. In the total group of patients untoward effects were few.
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T HE initial work on the use of molar sodium lactate was reported from this laboratory in May, 1955,1 on the basis of a series of 6 cases. At that time its use was discussed in the following conditions: restoring cardiac beating during cardiac arrest in Stokes-Adams attacks and during episodes of cardiac arrest of other etiologies, and increasing the slow ventricular rates of sinus bradyeardia and partial and complete A-V heart block. The rationale was based on an entirely different principle in therapy from that previously used in the human subject (e.g., atropine and sympathomimetic drugs). Its efficacy apparently depends upon an alteration in the electrolyte pattern in the extracellular fluid, which becomes more physiologic or tends to increase cardiac rhythmicity.
Since this report, further communications2 -4 amplified these initial observations, which included our preliminary impressions regarding the dose, route, and speed of administration, toxic effects, and possible modes of action. Subsequently, our experience has been ex- situations mentioned above and in addition have elaborated on 2 other conditions in which it has manifested salutory effects. Table 1 summarizes the number of subjects in each of the different categories studied. For the sake of conciseness only the pertinent data in each category will be briefly discussed.
RESULTS
A. The data on the effects of molar sodium lactate in normal patients have been previously presented. No untoward effects were observed.2 B. Ten patients, ranging in age from 52 to 81 years, manifested clinical and electrocardiographic evidence of varying degrees of myocardial abnormality and myocardial damage (including partial A-V block). Untoward effects were observed in 4 patients and consisted of transient T-wave inversion (2 cases) and transient extrasystoles (2 cases).2' 3 These effects were observed in older patients who presented a severe grade of myocardial damage; they were transient and persisted for only 1 or 2 minutes after cessation of the infusion. In the presence of partial A-V block (6 cases) the alterations in the atrial and ventricular rates were slight and insignificant in the doses given. The chief exception was observed in the presence of atrial fibrillation with slow ventricular rates ranging from 40 to 60 per minute (3 cases). In these patients the ventricular rate was significantly increased (by 10 to 40 beats per minute) following the infusion.
C. In 6 of 8 patients who had evidence of myocardial abnormality with sinus bradyeardia there was a significant increase in the ventricu- In case 10 sympathomimetic agents temporarily stopped the Stokes-Adams seizures, and in case 6 the combination of sympathomimetic agents and molar sodium lactate appeared to be more effective than either drug alone. Restoration of ventricular beating after sodium lactate occurred in 2 patients (cases 2 and 6) in spite of episodes of ventricular flutter and fibrillation. Case 6 is particularly interesting in that the mechanism of all of the many StokesAdams seizures was paroxysmal ventricular tachycardia-flutter and fibrillation. The intravenous administration of molar sodium lactate markedly diminished the frequency of these paroxysms ( fig. 3 ). In 2 instances (cases 5 and 6), however, the molar sodium lactate solution, although initially effective, ultimately failed to influence the episodes of cardiac standstill and death ensued.
Six of these 10 patients survived (cases 2-4, 7-9) and were ultimately discharged from the hospital. In 5 of the 6 the administration of molar sodium lactate was apparently life-saving. Other similar patients have been reported who responded to sodium lactate after sympathomimetic and vagolytic drugs had failed.5' 6 Patient 7 continued to have episodes of ventricular standstill while on the artificial electric pacemaker and showed no signs over a 40-hour period of observation of spontaneous idioventricular beating. Thirty minutes after intravenous molar sodium lactate the pacemaker was discontinued and the spontaneous idioventricular beating continued; this patient was ultimately discharged from the hospital 6 weeks later. Curiously enough, none of these patients with multiple Stokes-Adams attacks in association with complete A-V block manifested extrasystoles, during the period of observation, even after large amounts of the drug.
F. Molar sodium lactate was used in 12 cases of cardiac arrest occurring during surgery. Surgery was performed for the following conditions: congenital heart disease (5 patients), calcific aortic stenosis (3 patients), mitral insufficiency (2 patients), mitral stenosis (1 patient), mitral insufficiency and mitral stenosis (1 patient In many of these patients no lasting resuscitation could have been achieved and, therefore oxygen and artificial respiration were not used. In others the time interval from cessation of cardiac beating to resuscitative attempts was so long that the chance of reviving the patient was gone. In the cases seen within 2 to 3 minutes following ventricular standstill, successful restoration of cardiac beating of variable duration was frequently encountered. Two such cases have been previously reported ;1 4 in them the administration of sodium lactate, oxygen, and artificial respiration resulted in a gradual elevation of the blood pressure to normal levels, improvement in the skin color and a return of the electrocardiogram to a normal configuration. Our experience with terminal cardiac arrest suggests that where the cause of the arrest is a sudden process (independent of a chronic incurable disease), the administration of molar sodium lactate together with other resuscitative measures might resuscitate the heart, much as it has in the surgical group.
In the presence of cardiac arrest occurring during Stokes-Adams seizures and occurring terminally, the question often arises how the 
B. Stokes-Adams Attacks
Since molar sodium lactate has a relatively short effect of about 2 hours it is not indicated unless the patient is having frequent, repeated episodes or, perhaps, at the precise time of a solitary attack. For the occasional or isolated Stokes-Adams episode long-acting sympathomimetic drugs are the preferred method of treatment. We have recently been using oral molar sodium lactate 90 ml. q.i.d. with promising results in an attempt to prevent or abort these occasional attacks.
Dosage. For multiple Stokes-Adams attacks, 40 to 80 ml. may be given intravenously in 1 to 2 minutes during an attack and may be followed by an intravenous infusion at the rate of 60 to 150 drops per minute, the exact rate and the total amount given being dependent upon the effects observed. As the ventricular rate increases the infusion should be slowed; when the pacemaker maintains a satisfactory rate and the episodes of cardiac arrest are abolished, the infusion should be stopped. From 240 ml. within 30 minutes to 1000 ml. in 6 hours have been given without untoward effects (table 2).
C. Cardiac Arrest During Surgery
The exact conditions under which sodium lactate is best employed for this condition requires further investigation. Dosage. 1 Mechanism of Effects The mechanism of action of molar sodium lactate in increasing cardiac rhythmicity is still under investigation. The following mechanisms were originally postulated 4; (a) the production of alkalosis increased the irritability of the myocardium, (b) the increase in the sodium raised the height of the action potential, (c) the lactate provided additional fuel for the heart, (d) a vagolytic effect increased the cardiac rate.' Recently, we have suggested that one of the maj or factors is a decrease in the potassium in the extracellular fluid, which is accomplished by expansion of the extracellular space and movement of potassium intracellularly.7 10 A markedly increased rhythmicity of cardiac pacemakers by a low serum potassium has recently been documented in man and animals.3' 10-12 A more favorable Na:K ratio is probably an additional factor. The effects on rhythmicity, while due chiefly to a variation in extracellular potassium, may be influenced indirectly by other electrolytes, e.g., sodium, calcium, and to a lesser degree, by magnesium.
Comparison of Sodium Lactate with Sodium
Bicarbonate and Sodium Chloride The original purpose of giving molar sodium lactate was to use a convenient, established, and relatively safe method of producing a mild grade of alkalosis. As far as we know, this principle was previously employed in the perfused heart,' [1] [2] [3] [4] [5] [6] but has never been used in the intact animal or the human subject to increase cardiac rhythmicity. Substances with similar action may produce qualitatively similar effects (e.g., sodium bicarbonate), but sodium bicarbonate may be somewhat more toxic'7' 18 than sodium lactate, since it produces a marked shift in the pH quite rapidly. After our original observations we have studied the effect of sodium bicarbonate clinically and experimentally, for example, in hyperpotassemia in the nephrectomized dog; while the results are qualitatively similar, they are less marked with sodium bicarbonate and of shorter duration than with molar sodium lactate.'0 Sodium chloride was even less effective than sodium bicarbonate.'0 The chloride radical is a powerful anion, which tends to decrease the pH, thereby preventing or minimizing the decrease in extracellular potassium.
In summary, while similar in effect to sodium bicarbonate and sodium chloride, thus far molar sodium lactate would appear to be superior to them in the clinical states mentioned above.
Toxic Effects and Contraindications
Patients with complete A-V block are especially subject to develop ectopic rhythms because of areas of increased or decreased irritability in the heart muscle. The nodal or idioventricular pacemaker is notoriously unstable and any factor that increases cardiac work, such as the rapid infusion of fluid or hypertonic solutions (molar sodium lactate), might precipitate ectopic rhythms of various types. This is particularly likely when there are ectopic beats in the control tracing.
Extrasystoles are an important evidence of toxicity due to molar sodium lactate. They could result from the sudden increase in cardiac work or the lowering of serum potassium as a consequence of the production of or aggravation of alkalosis. Obviously, this toxic effect would tend to occur more commonly in the presence of established cardiac irritability, either latent or manifested by extrasystoles. In a general way, patients with severely diseased hearts and those with complete atrioventricular block belong in this category.
In early observations we showed that molar sodium lactate would increase cardiac rhythmicity in asymptomatic complete atrioventricular block. ' 3' 4 The ventricular rate increased in 9 patients of this type (53 per cent); however, extrasystoles were produced or were increased by molar sodium lactate in 5 subjects (29 per cent). We do not recommend molar sodium lactate for routine use in these cases of asymptomatic complete heart block, nor are sympathomimetic drugs routinely given to this group.
With the cessation of the infusion of molar sodium lactate the ectopic rhythm disappeared in a few seconds or minutes. It seems to us that this rapid cessation is less true of ventricular tachycardia resulting from the use of epinephrine or Isuprel; in these instances the effects are not easily reversible and ventricular fibrillation frequently ensues.
It is well documented that epinephrine may produce ventricular fibrillation, particularly in a damaged heart. Isuprel also tends to produce ventricular ectopic beats and ventricular fibrillation. Recently Zoll and co-workers'9 stated, "epinephrine, norepinephrine, and isopropylnorepinephrine differed only quantitatively .... Isopropylnorepinephrine sometimes excited multifocal ventricular activity in the same dose required to arouse an idioventricular pacemaker; the effect on the blood pressure, if any, was a depressor one."
The abolition or notable decrease of extrasystoles and of paroxysmal tachycardia after molar sodium lactate presents an interesting phenomenon. This was observed in 3 cases with extrasystoles ( fig. 5 ) and in 2 subjects with paroxysmal supraventricular tachycardia associated with hyperpotassemia ( fig. 6 ). While the mechanism in the latter group is more easily understandable, it is more difficult to explain the former. The following possibilities may be considered: (a) mild forms of hyperkalemia may have been unrecognized, (b) an increased ventricular rate resulting from the lactate may prevent discharge of ectopic foci, and (c) the lactate ion might improve cardiac function by acting as a fuel.
The presence of ventricular extrasystoles occurring in association with complete atrioventricular block presents a difficult therapeutic problem. Many of these patients have additional complicating factors: coronary artery disease with chronic or subacute myocardial infarction, congestive heart failure, electrolyte imbalance, or some other cause of cardiac irritability. Unless the extrasystoles are the result of a transient reversible factor, the prognosis in this group is poor, since they have an increased susceptibility to the development of ventricular tachycardia and ventricular fibrillation, leading to potentially fatal StokesAdams attacks. The use of quinidine or procaine amide is contraindicated because, while these drugs may abolish the extrasystoles, they further depress already depressed ventricular pacemakers. Sympathomimetic drugs in the form of epinephrine or Isuprel are also dangerous because of their tendency to increase cardiac irritability, which may increase the rhythmicity of the idioventricular pacemaker, but in our experience has also increased the frequency of the ventricular premature contractions and caused runs of ventricular tachycardia.
In summary, the following circumstances either contraindicate the use of molar sodium lactate or indicate extreme caution in its use; (1) the appearance or increased frequency of extrasystoles following the administration of sodium lactate; (2) severe heart damage, particularly in association with overt or impending congestive heart failure; (3) hypokalemia or alkalosis. SUMMARY Since our initial observations of the cardiovascular effects of molar and 0.50-molar sodium lactate, we have extended our experience to include 101 patients. Its value in certain clearly defined conditions has become apparent. In these sodium lactate has proved to be an extremely valuable addition to the therapeutic regimen.
Molar sodium lactate is shown to be a physiologic, safe, and rapid means of reversing the cardiotoxic manifestations of severe hyperpotassemia. The drug was successfully used in 10 patients with multiple Stokes-Adams seizures that occurred within a brief period of time, generally after sympathomimetic and vagolytic agents had been either totally ineffective or only partially effective. In addition, 12 cases of cardiac arrest occurring during intracardiac surgery were treated with molar sodium lactate within variable periods following the cardiac arrest-7 were successfully resuscitated for varying periods of time and 4 ultimately lived and were discharged from the hospital. In general, the usual therapeutic measures for cardiac arrest had been unsuccessfully tried prior to the administration of molar sodium lactate.
The presence of extrasystoles in the control tracing either contraindicates the use of sodium lactate or makes it mandatory that it be given with extreme caution under constant electrocardiographic control. An increase in preexisting extrasystoles, short paroxysms of ventricular tachycardia, and the new development of extrasystoles have been observed. Congestive heart failure may also develop as another untoward effect of sodium lactate therapy.
Although qualitatively similar in its effects, molar sodium lactate was somewhat more effective over a longer period of time than sodium bicarbonate.
Preliminary comparisons with epinephrine and Isuprel have suggested that molar sodium lactate manifests less profibrillatory qualities when used in comparable effective doses under similar conditions. Because its action is based on a different principle from that of the vagolytic and sympathomimetic drugs, it may supplement these agents, and may also be effective in conditions where the others are entirely useless. Molar lactato de natrium es un medio physiologic, salve, e rapide pro reverter le manifestationes cardiotoxic de sever hyperkaliemia. Le droga esseva usate con successo in 10 patientes con multiple attaccos de StokesAdams occurrente intra un breve periodo de tempore, generalmente post que agentes sympathomimetic e vagolytic se habeva monstrate totalmente inefficace o solmente partialmente efficace. In plus, 12 casos de arresto cardiac occurrente durante operationes intracardiac esseva tractate con molar lactato de natrium intra variabile periodos post le arresto. Septe del patientes esseva resuscitate pro varie periodos de tempore, e 4 superviveva e quitava le hospital. In general, le usual mesuras therapeutic pro arresto cardiac habeva essite probate sin successo ante le administration de molar lactato de natrium.
Le presentia de extrasystoles in le electrocardiogramma preliminari es un contraindication del uso de lactato de natrium o al minus establi le necessitate de administrar le droga con alte grados de previdentia e sub le constante supervigilantia de observationes electrocardiographic. 
